Literature DB >> 19657335

Developmental and species-divergent globin switching are driven by BCL11A.

Vijay G Sankaran1, Jian Xu, Tobias Ragoczy, Gregory C Ippolito, Carl R Walkley, Shanna D Maika, Yuko Fujiwara, Masafumi Ito, Mark Groudine, M A Bender, Philip W Tucker, Stuart H Orkin.   

Abstract

The contribution of changes in cis-regulatory elements or trans-acting factors to interspecies differences in gene expression is not well understood. The mammalian beta-globin loci have served as a model for gene regulation during development. Transgenic mice containing the human beta-globin locus, consisting of the linked embryonic (epsilon), fetal (gamma) and adult (beta) genes, have been used as a system to investigate the temporal switch from fetal to adult haemoglobin, as occurs in humans. Here we show that the human gamma-globin (HBG) genes in these mice behave as murine embryonic globin genes, revealing a limitation of the model and demonstrating that critical differences in the trans-acting milieu have arisen during mammalian evolution. We show that the expression of BCL11A, a repressor of human gamma-globin expression identified by genome-wide association studies, differs between mouse and human. Developmental silencing of the mouse embryonic globin and human gamma-globin genes fails to occur in mice in the absence of BCL11A. Thus, BCL11A is a critical mediator of species-divergent globin switching. By comparing the ontogeny of beta-globin gene regulation in mice and humans, we have shown that alterations in the expression of a trans-acting factor constitute a critical driver of gene expression changes during evolution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657335      PMCID: PMC3749913          DOI: 10.1038/nature08243

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

1.  Antisense intergenic transcription in V(D)J recombination.

Authors:  Daniel J Bolland; Andrew L Wood; Colette M Johnston; Sam F Bunting; Geoff Morgan; Lyubomira Chakalova; Peter J Fraser; Anne E Corcoran
Journal:  Nat Immunol       Date:  2004-04-25       Impact factor: 25.606

2.  Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.

Authors:  Vijay G Sankaran; Tobias F Menne; Jian Xu; Thomas E Akie; Guillaume Lettre; Ben Van Handel; Hanna K A Mikkola; Joel N Hirschhorn; Alan B Cantor; Stuart H Orkin
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

3.  A new anti-hemoglobin F antibody against synthetic peptides for the detection of F-cell precursors (F-blasts) in bone marrow.

Authors:  J W Choi; Y Kim; M Fujino; M Ito
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

4.  GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells).

Authors:  M Jasinski; P Keller; Y Fujiwara; S H Orkin; M Bessler
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

5.  Bcl11a is essential for normal lymphoid development.

Authors:  Pentao Liu; Jonathan R Keller; Mariaestela Ortiz; Lino Tessarollo; Rivka A Rachel; Takuro Nakamura; Nancy A Jenkins; Neal G Copeland
Journal:  Nat Immunol       Date:  2003-04-28       Impact factor: 25.606

6.  DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.

Authors:  Guillaume Lettre; Vijay G Sankaran; Marcos André C Bezerra; Aderson S Araújo; Manuela Uda; Serena Sanna; Antonio Cao; David Schlessinger; Fernando F Costa; Joel N Hirschhorn; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

7.  Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.

Authors:  Iris T Chan; Jeffery L Kutok; Ifor R Williams; Sarah Cohen; Lauren Kelly; Hirokazu Shigematsu; Leisa Johnson; Koichi Akashi; David A Tuveson; Tyler Jacks; D Gary Gilliland
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

8.  Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.

Authors:  Benjamin S Braun; David A Tuveson; Namie Kong; Doan T Le; Scott C Kogan; Jacob Rozmus; Michelle M Le Beau; Tyler E Jacks; Kevin M Shannon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

9.  Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system.

Authors:  Jing Zhang; Merav Socolovsky; Alec W Gross; Harvey F Lodish
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

10.  Species-specific transcription in mice carrying human chromosome 21.

Authors:  Michael D Wilson; Nuno L Barbosa-Morais; Dominic Schmidt; Caitlin M Conboy; Lesley Vanes; Victor L J Tybulewicz; Elizabeth M C Fisher; Simon Tavaré; Duncan T Odom
Journal:  Science       Date:  2008-09-11       Impact factor: 47.728

View more
  190 in total

1.  Clan genomics and the complex architecture of human disease.

Authors:  James R Lupski; John W Belmont; Eric Boerwinkle; Richard A Gibbs
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

2.  KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.

Authors:  Dewang Zhou; Kaimao Liu; Chiao-Wang Sun; Kevin M Pawlik; Tim M Townes
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

3.  Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6.

Authors:  Jian Xu; Vijay G Sankaran; Min Ni; Tobias F Menne; Rishi V Puram; Woojin Kim; Stuart H Orkin
Journal:  Genes Dev       Date:  2010-04-15       Impact factor: 11.361

4.  Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells.

Authors:  Shalini A Muralidhar; Valya Ramakrishnan; Inderdeep S Kalra; Wei Li; Betty S Pace
Journal:  J Biol Chem       Date:  2010-11-13       Impact factor: 5.157

Review 5.  Functional analysis of erythrocyte determinants of Plasmodium infection.

Authors:  Amy K Bei; Manoj T Duraisingh
Journal:  Int J Parasitol       Date:  2012-04-19       Impact factor: 3.981

Review 6.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

7.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

8.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

9.  Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model.

Authors:  Mikiko Suzuki; Hiromi Yamazaki; Harumi Y Mukai; Hozumi Motohashi; Lihong Shi; Osamu Tanabe; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

10.  A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.

Authors:  Suthat Fucharoen; Adlette Inati; Noppadol Siritanaratku; Swee L Thein; William C Wargin; Suzanne Koussa; Ali Taher; Nattawara Chaneim; Michael Boosalis; Ronald Berenson; Susan P Perrine
Journal:  Br J Haematol       Date:  2013-03-27       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.